ANTHONY YOUNGER: Open Payments
NPI 1013753508 · HIGH POINT, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,227 in 62 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $196 · 2025 $1,227
Food & beverage: $1,227
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $569 |
| Novo Nordisk Inc | 5 | $227 |
| Viatris Specialty LLC | 4 | $81 |
| Lilly USA, LLC | 4 | $75 |
| Aimmune Therapeutics, Inc. | 3 | $53 |
| Verona Pharma, Inc. | 2 | $50 |
| Dexcom, Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| HARMONY BIOSCIENCES LLC | 1 | $19 |
Products named: VRAYLAR, QULIPTA, Wegovy, UBRELVY, Ozempic, YUPELRI, ZENPEP, MOUNJARO.
Industry payments across NC — which companies pay providers there.
